Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of pregabalin extended-release tablets under fasting conditions in healthy volunteers
CTR20221261Phase 2Active
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in diabetic polyneuropathy (DPN), postherpetic neuralgia (PHN), sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started May 2022; status: active.
02
Drugs
pregabalin
03
Conditions
diabetic polyneuropathy (DPN)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on CTR20221261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221261.